APA (7th ed.) Citation

Denkert, C., Romey, M., Swedlund, B., Hattesohl, A., Teply-Szymanski, J., Kommoss, S., . . . Rodepeter, F. (2022). Homologous recombination deficiency as an ovarian cancer biomarker in a real-world cohort: Validation of decentralized genomic profiling. The journal of molecular diagnostics, 24(12), . https://doi.org/10.1016/j.jmoldx.2022.09.004

Chicago Style (17th ed.) Citation

Denkert, Carsten, et al. "Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-world Cohort: Validation of Decentralized Genomic Profiling." The Journal of Molecular Diagnostics 24, no. 12 (2022). https://doi.org/10.1016/j.jmoldx.2022.09.004.

MLA (9th ed.) Citation

Denkert, Carsten, et al. "Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-world Cohort: Validation of Decentralized Genomic Profiling." The Journal of Molecular Diagnostics, vol. 24, no. 12, 2022, https://doi.org/10.1016/j.jmoldx.2022.09.004.